BioNotebook: United Therapeutics, Upsher-Smith, Intra-Cellular
This article was originally published in Scrip
Executive Summary
United Therapeutics subpoenaed; Upsher-Smith Phase III epilepsy drug reduces seizures; and Intra-Cellular Phase II schizophrenia drug meets endpoint.